SG10201912650QA - Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them - Google Patents

Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them

Info

Publication number
SG10201912650QA
SG10201912650QA SG10201912650QA SG10201912650QA SG10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA
Authority
SG
Singapore
Prior art keywords
nanoliposomes
corticosteroid
medicaments
prepare
methods
Prior art date
Application number
SG10201912650QA
Inventor
Subramanian Venkatraman
Jayaganesh V Natarajan
Anastasia Darwitan
Original Assignee
Univ Nanyang Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nanyang Tech filed Critical Univ Nanyang Tech
Publication of SG10201912650QA publication Critical patent/SG10201912650QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201912650QA 2015-12-17 2016-11-28 Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them SG10201912650QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201510370T 2015-12-17

Publications (1)

Publication Number Publication Date
SG10201912650QA true SG10201912650QA (en) 2020-02-27

Family

ID=59057346

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201912650QA SG10201912650QA (en) 2015-12-17 2016-11-28 Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them
SG11201805101RA SG11201805101RA (en) 2015-12-17 2016-11-28 Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201805101RA SG11201805101RA (en) 2015-12-17 2016-11-28 Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them

Country Status (4)

Country Link
US (1) US20180360758A1 (en)
CN (1) CN108430457A (en)
SG (2) SG10201912650QA (en)
WO (1) WO2017105344A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115523A1 (en) * 2004-12-01 2006-06-01 Konduri Kameswari S Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
WO2006027786A2 (en) * 2004-09-09 2006-03-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of liposomal glucocorticoids for treating inflammatory states
ES2498795T3 (en) * 2005-09-01 2014-09-25 Meda Ab Composition of liposomes containing antihistamines and corticosteroids and their use for the manufacture of a medicine to treat rhinitis and related disorders
EP2127639A1 (en) * 2008-05-26 2009-12-02 Universiteit Utrecht Holding B.V. Corticosteroid containing liposomes for treatment of cardiovascular diseases
US20130071321A1 (en) * 2010-05-28 2013-03-21 Purdue Research Foundation Delivery of agents to inflamed tissues using folate-targeted liposomes
DK2773325T3 (en) * 2011-11-04 2019-01-14 Enceladus Pharmaceuticals B V LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS BY HUMANS
US9393320B2 (en) * 2011-12-07 2016-07-19 Universidade Do Minho Liposomes and its production method
CN104173285A (en) * 2013-05-23 2014-12-03 上海市第七人民医院 Preparation method for triamcinolone acetonide acetate ultradeformable nanometer lipid vesicle spraying agent and application to target hypertrophic scars

Also Published As

Publication number Publication date
SG11201805101RA (en) 2018-07-30
US20180360758A1 (en) 2018-12-20
WO2017105344A1 (en) 2017-06-22
CN108430457A (en) 2018-08-21

Similar Documents

Publication Publication Date Title
HK1253674A1 (en) Compositions and methods for transient gene therapy with enhanced stability
IL249011A0 (en) Methods and compositions relating to exosomes
IL250744A0 (en) Method of producing palbociclib and pharmaceutical compositions comprising the same
EP3397261A4 (en) Methods and compositions relating to chondrisomes
HK1258062A1 (en) Methods of administering elagolix
HK1245606A1 (en) Group of stirring cutters
EP3377406A4 (en) Detachable pilotable capsules and aircrafts including detachable pilotable capsules
EP3337265A4 (en) Device and method relating to dual connectivity
IL257392B (en) Pyrazolyl-substituted heteroaryls and their use as medicaments
PL3137473T3 (en) Pt (iv) derivatives and nanocarriers comprising them
ZA201703398B (en) Pharmaceutical composition and methods
SG11201801856XA (en) Biaryl derivative and medicine containing same
PT3202759T (en) Alpha-aminoamide derivative compound and pharmaceutical composition comprising same
HK1256875A1 (en) Enhanced delivery of drugs to the brain
EP3201138A4 (en) Compositions and methods for selective anion removal
GB201502845D0 (en) Topical pharmaceutical formulation
HK1223837A1 (en) Compositions and methods for reducing overdose
GB201406172D0 (en) Therapy and pharmaceutical composition
ZA201607148B (en) Pharmaceutical composition including anti-fungal agent and steroid
HK1214767A1 (en) Tablet-formed pharmaceutical composition and preparation method thereof
EP3182968A4 (en) Capsaicinoids and uses thereof as medicaments
EP3464319A4 (en) Intermediates and processes to prepare anidulafungin
HK1255857A1 (en) Piercing needle-equipped cannula
SG11201702260RA (en) Anti-cancer agent and cancer cell killing method
SG11201505661XA (en) Characterizing tsv microfabrication process and products